Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Feb;12(1):15–19. doi: 10.1080/0962935031000096935

Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.

Mehmet Tarakçioğlu 1, Ayşe Binnur Erbağci 1, Celalettin Usalan 1, Rukiye Deveci 1, Ramazan Kocabaş 1
PMCID: PMC1781588  PMID: 12745544

Abstract

Chronic inflammation is a common feature of end-stage renal disease, which carries a heightened risk of atherosclerosis and other co-morbid conditions. Dialysis treatment per se can bring additional risk factors for inflammation, such as increased risk of local graft and fistula infections, impure dialysate or bio-incompatible membranes. Our study was designed to determine whether a hemodialysis session leads to an acute substantial alteration in the plasma levels of the proinflammatory cytokines interleukin (IL)-6, IL-1beta and tumor necrosis factor (TNF)-alpha, the T-lymphocyte activation factor soluble IL-2 receptor (sIL-2R), and an inflammation mediator and chemotactic granulocyte factor, IL-8, in end-stage renal disease patients receiving chronic intermittent HD. In this study, 21 (12 male/nine female) patients undergoing chronic hemodialysis were enrolled. The acute effect of a hemodialysis session on serum cytokine concentrations was assessed by comparison of pre-hemodialysis and post-hemodialysis determinations. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha levels were determined with chemiluminescence enzyme immunometric assays. A significant difference was not observed for IL-1beta, IL-6, TNF-alpha, and sIL-2R concentrations in pre-hemodialysis and post-hemodialysis specimens (p>0.05). Serum median (25th-75th percentiles) IL-8 concentration was 69.4 (34.9-110.3) pg/ml before hemodialysis, and decreased to 31.5 (18.0-78.8) pg/ml following hemodialysis (p: 0.006). Clearance of IL-8 increased by 0.47+/-0.08 pg/ml for each unit increase in pre-dialysis IL-8 (p<0.001) and decreased by 5.63+/-2.59 pg/ml for each unit increase in pre-dialysis urea mmol/l (p<0.05). In conclusion, the results of our study demonstrate that a hemodialysis session markedly decreases IL-8 concentration, which is significantly affected by pre-dialysis concentrations, indicating that removal of IL-8 is a concentration gradient-dependent action, but does not change the serum levels of IL-1beta, sIL-2R, IL-6, and TNF-alpha, underlining importance of the structural characteristics of the molecules.

Full Text

The Full Text of this article is available as a PDF (95.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aukrust P., Berge R. K., Ueland T., Aaser E., Damås J. K., Wikeby L., Brunsvig A., Müller F., Forfang K., Frøland S. S. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol. 2001 Feb;37(2):485–491. doi: 10.1016/s0735-1097(00)01110-4. [DOI] [PubMed] [Google Scholar]
  2. Cappelli G., DiFelice A., Perrone S., Ballestri M., Bonucchi D., Savazzi A. M., Ciuffreda A., Lusvarghi E. Which level of cytokine production is critical in haemodialysis? Nephrol Dial Transplant. 1998;13 (Suppl 7):55–60. doi: 10.1093/ndt/13.suppl_7.55. [DOI] [PubMed] [Google Scholar]
  3. Dugué B., Leppänen E. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin Chem Lab Med. 1998 May;36(5):323–325. doi: 10.1515/CCLM.1998.054. [DOI] [PubMed] [Google Scholar]
  4. Fischer K., Hamza A., Eismann R., Amoury M., Heynemann H., Fornara P. Differential diagnostic use of interleukin patterns in patients being monitored after transplantation. Clin Chim Acta. 2001 Aug 1;310(1):71–80. doi: 10.1016/s0009-8981(01)00525-3. [DOI] [PubMed] [Google Scholar]
  5. Fujimori A., Naito H., Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy. Artif Organs. 1998 Dec;22(12):1014–1017. doi: 10.1046/j.1525-1594.1998.06083.x. [DOI] [PubMed] [Google Scholar]
  6. Girndt M., Heisel O., Köhler H. Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol Dial Transplant. 1999 Mar;14(3):676–682. doi: 10.1093/ndt/14.3.676. [DOI] [PubMed] [Google Scholar]
  7. González C., Cava F., Ayllón A., Guevara P., Navajo J. A., González-Buitrago J. M. Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clin Chem Lab Med. 2001 Sep;39(9):836–841. doi: 10.1515/CCLM.2001.139. [DOI] [PubMed] [Google Scholar]
  8. Gu Y., Ding F., Qin H., Zhao H., Lin S. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Chin Med J (Engl) 2000 Apr;113(4):315–319. [PubMed] [Google Scholar]
  9. Heering P., Morgera S., Schmitz F. J., Schmitz G., Willers R., Schultheiss H. P., Strauer B. E., Grabensee B. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997 Mar;23(3):288–296. doi: 10.1007/s001340050330. [DOI] [PubMed] [Google Scholar]
  10. Herbelin A., Nguyen A. T., Zingraff J., Ureña P., Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990 Jan;37(1):116–125. doi: 10.1038/ki.1990.16. [DOI] [PubMed] [Google Scholar]
  11. Hoffmann J. N., Hartl W. H., Faist E., Jochum M., Inthorn D. Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes. Inflamm Res. 1997 Sep;46(9):342–347. doi: 10.1007/s000110050199. [DOI] [PubMed] [Google Scholar]
  12. Hon W. M., Lee J. C., Lee K. H. Effect of hemodialysis on plasma nitric oxide levels. Artif Organs. 2000 May;24(5):387–390. doi: 10.1046/j.1525-1594.2000.06496-2.x. [DOI] [PubMed] [Google Scholar]
  13. Kimmel P. L., Phillips T. M., Simmens S. J., Peterson R. A., Weihs K. L., Alleyne S., Cruz I., Yanovski J. A., Veis J. H. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998 Jul;54(1):236–244. doi: 10.1046/j.1523-1755.1998.00981.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lonnemann G., Koch K. M., Shaldon S., Dinarello C. A. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med. 1988 Jul;112(1):76–86. [PubMed] [Google Scholar]
  15. Millar A. B., Armstrong L., van der Linden J., Moat N., Ekroth R., Westwick J., Scallan M., Lincoln C. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 1993 Dec;56(6):1499–1502. doi: 10.1016/0003-4975(93)90740-9. [DOI] [PubMed] [Google Scholar]
  16. Sander A., Armbruster W., Sander B., Daul A. E., Lange R., Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med. 1997 Aug;23(8):878–884. doi: 10.1007/s001340050425. [DOI] [PubMed] [Google Scholar]
  17. Schiffl H., Lang S. M., Stratakis D., Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001 Sep;16(9):1863–1869. doi: 10.1093/ndt/16.9.1863. [DOI] [PubMed] [Google Scholar]
  18. Sester U., Sester M., Hauk M., Kaul H., Köhler H., Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000 Aug;15(8):1217–1223. doi: 10.1093/ndt/15.8.1217. [DOI] [PubMed] [Google Scholar]
  19. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant. 2001;16 (Suppl 7):36–40. doi: 10.1093/ndt/16.suppl_7.36. [DOI] [PubMed] [Google Scholar]
  20. Tarakçioglu M., Erbagci Ab, Cekmen M., Usalan C., Ciçek H., Ozaslan J., Camci C. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract. 2002 Jun;56(5):328–332. [PubMed] [Google Scholar]
  21. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001 Dec;12(4):375–391. doi: 10.1016/s1359-6101(01)00016-8. [DOI] [PubMed] [Google Scholar]
  22. Zamauskaite A., Perez-Cruz I., Yaqoob M. M., Madrigal J. A., Cohen S. B. Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant. 1999 Jan;14(1):49–55. doi: 10.1093/ndt/14.1.49. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES